Bank of New York Mellon’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-225,493
| Closed | -$5.43M | – | 4518 |
|
|
2023
Q1 | $5.43M | Sell |
225,493
-39,639
| -15% | -$955K | ﹤0.01% | 2259 |
|
|
2022
Q4 | $2.8M | Buy |
265,132
+51,102
| +24% | +$540K | ﹤0.01% | 2661 |
|
|
2022
Q3 | $963K | Buy |
214,030
+41,672
| +24% | +$187K | ﹤0.01% | 3218 |
|
|
2022
Q2 | $690K | Sell |
172,358
-32,555
| -16% | -$130K | ﹤0.01% | 3401 |
|
|
2022
Q1 | $1.5M | Sell |
204,913
-10,850
| -5% | -$79.4K | ﹤0.01% | 3086 |
|
|
2021
Q4 | $1.21M | Sell |
215,763
-12,806
| -6% | -$71.9K | ﹤0.01% | 3271 |
|
|
2021
Q3 | $1.46M | Buy |
228,569
+30,770
| +16% | +$197K | ﹤0.01% | 3185 |
|
|
2021
Q2 | $1.67M | Buy |
197,799
+17,770
| +10% | +$150K | ﹤0.01% | 3116 |
|
|
2021
Q1 | $1.89M | Buy |
180,029
+3,390
| +2% | +$35.6K | ﹤0.01% | 2953 |
|
|
2020
Q4 | $2.99M | Buy |
176,639
+5,123
| +3% | +$86.8K | ﹤0.01% | 2612 |
|
|
2020
Q3 | $2.2M | Buy |
171,516
+10,344
| +6% | +$133K | ﹤0.01% | 2612 |
|
|
2020
Q2 | $2.27M | Buy |
161,172
+138,666
| +616% | +$1.96M | ﹤0.01% | 2605 |
|
|
2020
Q1 | $207K | Sell |
22,506
-25,000
| -53% | -$230K | ﹤0.01% | 3725 |
|
|
2019
Q4 | $708K | Buy |
47,506
+35,428
| +293% | +$528K | ﹤0.01% | 3402 |
|
|
2019
Q3 | $82K | Buy |
+12,078
| New | +$82K | ﹤0.01% | 4045 |
|